Skip to main content
MIT Corporate Relations
MIT Corporate Relations
Search
×
Read
Watch
Attend
About
Connect
MIT Startup Exchange
Search
Sign-In
Register
Search
×
MIT ILP Home
Read
Faculty Features
Research
News
Watch
Attend
Conferences
Webinars
Learning Opportunities
About
Membership
Staff
For Faculty
Connect
Faculty/Researchers
Program Directors
MIT Startup Exchange
User Menu and Search
Search
Sign-In
Register
MIT ILP Home
Toggle menu
Search
Sign-in
Register
Read
Faculty Features
Research
News
Watch
Attend
Conferences
Webinars
Learning Opportunities
About
Membership
Staff
For Faculty
Connect
Faculty/Researchers
Program Directors
MIT Startup Exchange
Back to Program Directors
Irina S Sigalovsky
Director of Corporate Relations
Contact
isigal@mit.edu
Assistant
Austin Crann
acrann@mit.edu
Bio
Irina Sigalovsky joined the Office of Corporate Relations as a Senior Industrial Liaison Officer in May 2016. She was promoted to Director of Corporate Relations in February 2022.
Dr. Sigalovsky comes to MIT with 10 years of international experience in strategic innovation, technology forecasting and external (open) innovation. Prior to MIT, Irina worked at GEN3 Partners, Inc. of Boston where she was, most recently, a Senior Principal collaborating with clients to focus their innovation investments, partnering with CTOs, CIOs, directors of R&D, and Directors of External Innovation to execute strategic innovation agendas, and developing business globally. Before GEN3 Partners, Dr. Sigalovsky was at Mass General Hospital/Harvard Medical School, NMR Imaging Center as a Senior Research Fellow where she pioneered novel approach in MRI to study gray matter architecture in living humans in a way previously possible only in postmortem tissue.
Throughout her career, Irina has held teaching positions as Lecturer (Tufts University), and Guest Lecturer (MIT Sloan School, X-Prize Lab@MIT, MIT HST, Boston University, Northeastern University and Harvard University).
Irina earned her B.S. degree in Biomedical Engineering from Boston University and her Ph.D. in Neuroscience from the MIT/Harvard Medical School Division of Health Sciences and Technology (HST).